Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Weak
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Website
N/ATelephone
64.044.911.5065
Address
Grafton 57 Symonds Street Level 6, Equitable House Auckland 1010
Description
N/A
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.01 - 0.03
Trade Value (12mth)
AU$584.00
1 week
-3.57%
1 month
12.5%
YTD
28.57%
1 year
35%
All time high
0.18
EPS 3 yr Growth
-53.60%
EBITDA Margin
-120.90%
Operating Cashflow
-$2m
Free Cash Flow Return
-70.60%
ROIC
-71.20%
Interest Coverage
N/A
Quick Ratio
4.60
Shares on Issue (Fully Dilluted)
553m
HALO Sector
Healthcare
Next Company Report Date
N/A
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
08 May 25 |
Details of Auditor Appointment/Resignation
×
Details of Auditor Appointment/Resignation |
01 May 25 |
Published Saudi Arabia Study Confirms TruScreen's Results
×
Published Saudi Arabia Study Confirms TruScreen's Results |
30 April 25 |
TruScreen Re-enters India Appointing New Distributor
×
TruScreen Re-enters India Appointing New Distributor |
23 April 25 |
Vale Professor Ron Jones
×
Vale Professor Ron Jones |
22 April 25 |
TruScreen Launches 260,000 Women Screening Program in HCMC
×
TruScreen Launches 260,000 Women Screening Program in HCMC |
07 April 25 |
Changes to US and China Tariff Regimes Have No Impact on TRU
×
Changes to US and China Tariff Regimes Have No Impact on TRU |
24 March 25 |
TruScreen to Present at Singapore Health Day Forum
×
TruScreen to Present at Singapore Health Day Forum |
10 March 25 |
Appendix 2A
×
Appendix 2A |
10 March 25 |
Capital Change Notice
×
Capital Change Notice |
10 March 25 |
Cleansing Notice
×
Cleansing Notice |
03 March 25 |
Investor Presentation March 2025
×
Investor Presentation March 2025 |
03 March 25 |
Key Markets Update and Revenue Guidance
×
Key Markets Update and Revenue Guidance |
27 February 25 |
TruScreen Signs MOU with Hangzhou Dalton Bioscience
×
TruScreen Signs MOU with Hangzhou Dalton Bioscience |
29 January 25 |
TruScreen Appoints Indonesian Distributor
×
TruScreen Appoints Indonesian Distributor |
13 January 25 |
TruScreen Invited to Present at WHO AI Collaboration Meeting
×
TruScreen Invited to Present at WHO AI Collaboration Meeting |
29 November 24 |
Half Yearly Report and Accounts
×
Half Yearly Report and Accounts |
25 November 24 |
5-Year Cervical Cancer Screening Progam Launched in Vietnam
×
5-Year Cervical Cancer Screening Progam Launched in Vietnam |
12 November 24 |
TruScreen Key Markets Update
×
TruScreen Key Markets Update |
11 November 24 |
Germany's Springer Nature Journal Publication on Truscreen
×
Germany's Springer Nature Journal Publication on Truscreen |
29 October 24 |
Ranked in Top 6 Global Women's Health Startups 2024 Report
×
Ranked in Top 6 Global Women's Health Startups 2024 Report |
03 October 24 |
TruScreen Featured in UNITAID Technology Landscape Report
×
TruScreen Featured in UNITAID Technology Landscape Report |
23 September 24 |
Dr Dexter Cheung Appointed Chair of Technology Committee
×
Dr Dexter Cheung Appointed Chair of Technology Committee |
03 September 24 |
Results of Meeting
×
Results of Meeting |
03 September 24 |
Annual Shareholder Meeting Presentation
×
Annual Shareholder Meeting Presentation |
16 August 24 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.